Coloplast As ADR (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,087,989 | 1,058,312 | 977,823 | 1,004,015 | 1,023,829 |
| Cost of Goods | 343,761 | 342,681 | 310,702 | 325,240 | 340,451 |
| Gross Profit | 744,228 | 715,631 | 667,121 | 678,775 | 683,377 |
| Operating Expenses | 474,786 | 437,665 | 412,855 | 416,365 | 403,081 |
| Operating Income | 270,203 | 278,647 | 254,968 | 262,650 | 280,748 |
| Interest Expense | 30,099 | 63,122 | 38,803 | 38,440 | 48,101 |
| Other Income | 4,459 | -11,408 | -5,785 | 28,580 | 3,457 |
| Pre-tax Income | 244,563 | 204,118 | 210,380 | 252,790 | 236,103 |
| Income Tax | 106,383 | 81,678 | 81,697 | 103,603 | 42,684 |
| Net Income Continuous | 138,180 | 122,441 | 128,683 | 149,188 | 193,419 |
| Net Income | $138,180 | $122,441 | $128,683 | $149,188 | $193,419 |
| EPS Basic Total Ops | 0.06 | 0.05 | 0.06 | 0.07 | 0.09 |
| EPS Basic Continuous Ops | 0.06 | 0.05 | 0.06 | 0.07 | 0.08 |
| EPS Diluted Total Ops | 0.06 | 0.05 | 0.06 | 0.07 | 0.09 |
| EPS Diluted Continuous Ops | 0.06 | 0.05 | 0.06 | 0.07 | 0.08 |
| EPS Diluted Before Non-Recurring Items | 0.07 | 0.06 | 0.06 | 0.07 | 0.08 |
| EBITDA(a) | $331,011 | $338,210 | $302,916 | $309,521 | $330,507 |